期刊文献+

Response of porcine hepatocytes in primary culture to plasma from severe viral hepatitis patients 被引量:6

Response of porcine hepatocytes in primary culture to plasma from severe viral hepatitis patients
下载PDF
导出
摘要 AIM: To observe the effects of plasma from patients with severe viral hepatitis (SVHP) on the growth and metabolism of porcine hepatocytes and the clinical efficiency of bioartificial liver device.METHODS: Hepatocytes were isolated from male porcines by collagenase perfusion. The synthesis of DNA and total protein, leakages of AST and LDH, changes in glutathione (GSH), catalase and morphology of porcine hepatocytes exposed to SVHP were investigated to indicate the effect of plasma from patients with severe hepatitis on the growth, injury, detoxification, and morphology of porcine hepatocytes.RESULTS: The synthesis of DNA and protein was inhibited in the medium containing 100% SVHP compared to the controls. The leakages of LDH and AST increased in porcine hepatocytes following exposure to 100% SVHP for 5 h. The difference between 100% SVHP and 10% newborn calf serum (NCS) was significant in t-test (LDH: t = 24.552, P = 0.001; AST: t = 4.169, P =0.014). After exposure to SVHP for 24 h, alterations in GSH status were significant (F = 2.746, P<0.05) between porcine hepatocytes in 100% SVHP and 10% NCS, but no alteration occurred in the culture medium after 48 h (F = 4.378, P<0.05). A similar profile was observed in catalase activity. Many round vacuoles were observed in porcine hepatocytes cultured in SVHP. The membranes of these cells became indistinct and almost all the cells died on d 5.CONCLUSION: Plasma from patients with severe hepatitis inhibits the growth, injures membrane, disturbs GSH homeostasis and induces morphological changes of porcine hepatocytes. It is suggested that SVHP should be pretreated to reduce the toxin load and improve the performance of porcine hepatocytes in extracorporeal liver-support devices. AIM: To observe the effects of plasma from patients with severe viral hepatitis (SVHP) on the growth and metabolism of porcine hepatocytes and the clinical efficiency of bioartificial liver device. METHODS: Hepatocytes were isolated from male porcines by collagenase perfusion. The synthesis of DNA and total protein, leakages of AST and LDH, changes in glutathione (GSH), catalase and morphology of porcine hepatocytes exposed to SVHP were investigated to indicate the effect of plasma from patients with severe hepatitis on the growth, injury, detoxification, and morphology of porcine hepatocytes. RESULTS: The synthesis of DNA and protein was inhibited in the medium containing 100% SVHP compared to the controls. The leakages of LDH and AST increased in porcine hepatocytes following exposure to 100% SVHP for 5 h. The difference between 100% SVHP and 10% newborn calf serum (NCS) was significant in t-test (LDH: t = 24.552, P = 0.001; AST: t = 4.169, P = 0.014). After exposure to SVHP for 24 h, alterations in GSH status were significant (F = 2.746, P〈0.05) between porcine hepatocytes in 100% SVHP and 10% NCS, but no alteration occurred in the culture medium after 48 h (F = 4.378, ,P〈0.05). A similar profile was observed in catalase activity. Many round vacuoles were observed in porcine hepatocytes cultured in SVHR The membranes of these cells became indistinct and almost all the cells died on d 5. CONCLUSION: Plasma from patients with severe hepatitis inhibits the growth, injures membrane, disturbs GSH homeostasis and induces morphological changes of porcine hepatocytes, It is suggested that SVHP should be pretreated to reduce the toxin load and improve the performance of porcine hepatocytes in extracorporeal liver-support devices.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第48期7585-7590,共6页 世界胃肠病学杂志(英文版)
基金 Supported by National Natural Science Foundation of China,No. 30470458
关键词 肝细胞 病毒肝炎 等离子体 细胞毒性 Bioartificial liver Porcine hepatocytes Cellculture Plasma toxicity
  • 相关文献

参考文献29

  • 1[1]Hui T,Rozga J,Demetriou AA.Bioartificial liver support.J Hepatobiliary Pancreat Surg 2001; 8:1-15
  • 2[2]Hughes RD,Cochrane AM,Thomson AD,Murray-Lyon IM,Williams R.The cytotoxicity of plasma from patients with acute hepatic failure to isolated rabbit hepatocytes.Br J Exp Pathol 1976; 57:348 348-353
  • 3[3]Gove CD,Hughes RD,Williams R.Rapid inhibition of DNA synthesis in hepatocytes from regenerating rat liver by serum from patients with fulminant hepatic failure.Br J Exp Pathol 1982; 63:547-553
  • 4[4]Shi Q,Gaylor JD,Cousins R,Plevris J,Hayes PC,Grant MH.The effects of serum from patients with acute liver failure on the growth and metabolism of Hep G2 cells.Artif Organs 1998;22:1023-1030
  • 5[5]McCloskey P,Tootle R,Selden C,Larsen F,Roberts E,Hodgson HJ.Modulation of hepatocyte function in an immortalized human hepatocyte cell line following exposure to liver-failure plasma.Artif Organs 2002; 26:340-348
  • 6[6]Pazzi P,Morsiani E,Vilei MT,Granato A,Rozga J,Demetriou AA,Muraca M.Serum bile acids in patients with liver failure supported with a bioartificial liver.Aliment Pharmacol Ther 2002; 16:1547-1554
  • 7[7]Rozga J,Williams F,Ro MS,Neuzil DF,Giorgio TD,Backfisch G,Moscioni AD,Hakim R,Demetriou AA.Development of a bioarti.cial liver:properties and function of a hollow module inoculated with livers cells.Hepatology 1993; 17:258-265
  • 8[8]Watanabe FD,Mullon CJ,Hewitt WR,Arkadopoulos N,Kahaku E,Eguchi S,Khalili T,Arnaout W,Shackleton CR,Rozga J,Solomon B,Demetriou AA.Clinical experience with a bioartificial liver in the treatment of severe liver failure.A phase I clinical trial.Ann Surg 1997; 225:484-91; discussion 491-494
  • 9[9]Khalili TM,Navarro A,Ting P,Kamohara Y,Arkadopoulos N,Solomon BA,Demetriou AA,Rozga J.Bioarti.cial liver treatment prolongs survival and lowers incranial pressure in pigs with fulminant hepatic failure.ArtifOrgans 2001; 25:566-570
  • 10[10]Nagaki M,Miki K,Kim YI,Ishiyama H,Hirahara I,Takahashi H,Sugiyama A,Muto Y,Moriwaki H.Development and characterization of a hybrid bioartificial liver using primary hepatocytes entrapped in a basement membrane matrix.Dig Dis Sci 2001; 46:1046-1056

同被引文献63

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部